The Asia-Pacific Antitrust Review 2017

India: Competition and the Pharmaceutical Sector

04 April 2017

The significance of the pharmaceutical sector for any country’s health and wellbeing is obvious. There exists an ever-increasing demand for safe, efficacious, innovative and, most importantly, affordable medicines – a balance that is not easy to achieve and often complicated on account of high research and development costs and intellectual property barriers. The significance of the sector also implies that it is highly regulated, with a multitude of regulators and laws controlling various aspects of the sector, including development, testing, manufacturing, marketing, procurement, patents, data protection and trademarks. The sector is also prone to competition distortions that require specific intervention of the competition authorities.

Interested in becoming a GCR author? Please contact our Insight Manager.

Get in touch